Found 5 matching trials
Subjects With Subjective Cognitive Decline: 18F-Florbetaben Positron Emission Tomography Study
PHASE2Phase II, open-label clinical trial with a medicinal product. A total of 30...
Location
Multiple Locations
Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With AD
PHASE4This phase 4 study will explore, in the context of the present French clini...
Location
Coordinating center (Hôpital de La Timone) and 18 associated centers in France
Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies
EARLY_PHASE1The overall goal of this imaging trial is to characterize \[18F\]MNI-815, a...
Location
Molecular NeuroImaging, LLC
Test-retest Study With [18F]FBB in Cardiac Amyloidosis
PHASE1This study is an open-label study to evaluate and characterize test-retest ...
Location
Royal Free Hospital
Alzheimer's Disease Research Center (ADRC) PET Component Study
PHASE2The purpose of this study is to further engage and characterize Alzheimer's...
Status
Enrolling By Invitation
Location
Columbia University Irving Medical Center